Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)

NCT03885934 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

606

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: V114
BIOLOGICAL: Prevnar 13®

Sponsor

Merck Sharp & Dohme LLC